Effectiveness of the Dry Needling Approach in Patients With Tension-Type Headache

Tension-Type Headache Clinical Trial

Official title:

Effectiveness of the Dry Needling Approach in Patients With Tension-Type Headache

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06108180
• Other study ID #: RAT 2023-195
• Status: Recruiting
• Phase: N/A
• Start date: October 23, 2023
• Est. completion date: December 5, 2023

Study information

• Verified date: November 2023
• Source: Universidad de Zaragoza
• Contact: Sofía Monti
• Phone: +34603489828
• Email: smonti[@]unizar.es
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Randomized Single-Blind Clinical Trial in which the treatment will be administered through 3 sessions of dry needling in the cervical, cranial, and facial musculature in patients with frequent and chronic tension-type headache.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 5, 2023
• Est. primary completion date: November 17, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with a diagnosis of tension headache according to IHS

Exclusion Criteria:

• Documented major trauma through medical history in the cervical area and/or recent surgery.
• Pregnancy.
• Generalized pain.
• Inflammatory, hormonal, or neurological disorders.
• Tendon disorders in the upper extremities.
• Severe psychiatric illnesses.
• Inability to complete the form in Spanish.
• Having a pacemaker (due to the use of equipment with magnetic sensors).
• Specific contraindications to invasive or conservative physiotherapy (infection, fever, hypothyroidism, wounds in the puncture area, metal allergies, cancer, systemic diseases, or belonephobia).
• Having received physiotherapy treatment for the condition in the past month.

Related Conditions & MeSH terms

• Dry Needling
• Headache
• Tension-Type Headache

Intervention

Other:
• Dry Needling
3 treatment to eliminate active trigger points that patients have

Locations

Country	Name	City	State
Spain	Centro Clínico de Fisioterapia OMT-E	Zaragoza

Sponsors (1)

Lead Sponsor	Collaborator
Universidad de Zaragoza

Country where clinical trial is conducted

Spain, 

References & Publications (4)

Cerezo-Tellez E, Torres-Lacomba M, Fuentes-Gallardo I, Perez-Munoz M, Mayoral-Del-Moral O, Lluch-Girbes E, Prieto-Valiente L, Falla D. Effectiveness of dry needling for chronic nonspecific neck pain: a randomized, single-blinded, clinical trial. Pain. 2016 Sep;157(9):1905-1917. doi: 10.1097/j.pain.0000000000000591. — View Citation

Fernandez-de-Las-Penas C, Ge HY, Arendt-Nielsen L, Cuadrado ML, Pareja JA. The local and referred pain from myofascial trigger points in the temporalis muscle contributes to pain profile in chronic tension-type headache. Clin J Pain. 2007 Nov-Dec;23(9):786-92. doi: 10.1097/AJP.0b013e318153496a. — View Citation

Ferrante T, Manzoni GC, Russo M, Camarda C, Taga A, Veronesi L, Pasquarella C, Sansebastiano G, Torelli P. Prevalence of tension-type headache in adult general population: the PACE study and review of the literature. Neurol Sci. 2013 May;34 Suppl 1:S137-8. doi: 10.1007/s10072-013-1370-4. — View Citation

Stephens LR, Humphrey JD, Little PB, Barnum DA. Morphological, biochemical, antigenic, and cytochemical relationships among Haemophilus somnus, Haemophilus agni, Haemophilus haemoglobinophilus, Histophilus ovis, and Actinobacillus seminis. J Clin Microbiol. 1983 May;17(5):728-37. doi: 10.1128/jcm.17.5.728-737.1983. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Active trigger points	The investigators assess the sensitivity of trigger points using algometry to determine which points reproduce the participants tensional-type headache.	1 month
Secondary	cervical ROM	general cervical range of movement, upper and lower cervical	1 month